Advanced Medical Research, PC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)1 trial
• Psoriasis1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Regeneron Pharmaceuticals1 trial
• Takeda1 trial

Closed trials

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· Phase 3· Takeda· Source

• Completed

  Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

  NCT05590585· Phase 4· Regeneron Pharmaceuticals· Source